Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Otto Krieger"'
Autor:
Thomas Nösslinger, Michelle M. Le Beau, Peter L. Greenberg, José Cervera, Isabel Granada, Mar Mallo, Peter Valent, Christa Fonatsch, Ulrich Germing, Francesc Solé, Aristoteles Giagounidis, Michael Pfeilstöcker, John M. Bennett, Marylin L. Slovak, Julie Schanz, E. Luño, Michael Lübbert, Reinhard Stauder, Kazuma Ohyashiki, Otto Krieger, Detlef Haase, Barbara Hildebrandt, Carlo Aul
Publikováno v:
GENES CHROMOSOMES & CANCER
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
The study analyzes the clonal architecture and the abnormalities involved in a series of 191 patients with myelodysplastic syndromes (MDS) and 2-3 clonal abnormalities. All patients were extracted from an international database. The patients were cla
Autor:
Georg Kemmler, Anabel Schönmetzler, Friedrich Wimazal, Christoph Bammer, Peter Valent, Thomas Nösslinger, Reinhard Stauder, Wolfgang R. Sperr, Michael Pfeilstöcker, Otto Krieger
Publikováno v:
Journal of Geriatric Oncology. 5:299-306
Myelodysplastic syndromes (MDS) are typical diseases of the elderly. The clinical outcome of a well-characterized cohort of patients with MDS was analyzed for prevalence and impact of comorbidities to establish the basis for tailored treatment algori
Autor:
Heinz Tüchler, Ch. Gruber, Kathrin Nachtkamp, Karl Sotlar, Petra Reinecke, H. Bösmüller, Friedrich Wimazal, W. Sega, Otto Krieger, Ulrich Germing, H.-P. Horny, Leonhard Müllauer, Sigrid Machherndl-Spandl, Wolfgang R. Sperr, Peter Valent
Publikováno v:
Annals of Hematology. 93:57-64
In a retrospective study, 43 patients with dysplastic neoplasms of the bone marrow (myelodysplastic syndromes and myelodysplastic/myeloproliferative-overlap neoplasms) associated with marked (grades 2-3) fibrosis were examined. Histopathologic and mo
Autor:
Yasushi Miyazaki, Arjan A. van de Loosdrecht, Mario Cazzola, Michael Pfeilstöcker, Heinz Tuechler, François Dreyfus, Alessandro Levis, Guillermo Garcia-Manero, Francesc Solé, Ulrich Germing, Detlef Haase, Michael Luebbert, David T. Bowen, Mikkael A. Sekeres, Sudhir Tauro, Guillermo Sanz, Pierre Fenaux, Marilyn L. Slovak, Teresa Vallespi, Wolfgang R. Sperr, Silvia Maria Meira Magalhães, Jaroslaw P. Maciejewski, Christa Fonatsch, Peter Valent, Otto Krieger, Julie Schanz, Andrea Kuendgen, John M. Bennett, Michelle M. Le Beau, Jaroslav Cermak, Reinhard Stauder, Hagop M. Kantarjian, Peter L. Greenberg, Luca Malcovati
Publikováno v:
Blood
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Blood, 128(16), 2096-2097. American Society of Hematology
Greenberg, P L, Tuechler, H, Schanz, J, Sanz, G, Garcia-Manero, G, Sole, F, Bennett, J M, Bowen, D, Fenaux, P, Dreyfus, F, Kantarjian, H, Kuendgen, A, Levis, A, Malcovati, L, Cazzola, M, Cermak, J, Fonatsch, C, Le Beau, M M, Slovak, M L, Krieger, O, Luebbert, M, Maciejewski, J, Magalhaes, S M M, Miyazaki, Y, Pfeilstoecker, M, Sekeres, M, Sperr, W R, Stauder, R, Tauro, S, Valent, P, Vallespi, T, van de Loosdrecht, A A, Germing, U & Haase, D 2016, ' Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes ', Blood, vol. 128, no. 16, pp. 2096-2097 . https://doi.org/10.1182/blood-2016-07-728766
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Blood, 128(16), 2096-2097. American Society of Hematology
Greenberg, P L, Tuechler, H, Schanz, J, Sanz, G, Garcia-Manero, G, Sole, F, Bennett, J M, Bowen, D, Fenaux, P, Dreyfus, F, Kantarjian, H, Kuendgen, A, Levis, A, Malcovati, L, Cazzola, M, Cermak, J, Fonatsch, C, Le Beau, M M, Slovak, M L, Krieger, O, Luebbert, M, Maciejewski, J, Magalhaes, S M M, Miyazaki, Y, Pfeilstoecker, M, Sekeres, M, Sperr, W R, Stauder, R, Tauro, S, Valent, P, Vallespi, T, van de Loosdrecht, A A, Germing, U & Haase, D 2016, ' Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes ', Blood, vol. 128, no. 16, pp. 2096-2097 . https://doi.org/10.1182/blood-2016-07-728766
To the editor: The recent article by Arber et al[1][1] detailing the 2016 revision of the World Health Organization (WHO) classification of myeloid malignancies and AML was timely and germane. Regarding myelodysplastic syndromes (MDS), the authors in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f3cdf649d08658df474afc1cf478962
https://europepmc.org/articles/PMC5341483/
https://europepmc.org/articles/PMC5341483/
Autor:
Peter Valent, Attilio Orazi, Guntram Büsche, Annette Schmitt-Gräff, Tracy I. George, Karl Sotlar, Berthold Streubel, Christine Beham-Schmid, Sabine Cerny-Reiterer, Otto Krieger, Arjan van de Loosdrecht, Wolfgang Kern, Kiyoyuki Ogata, Friedrich Wimazal, Judit Csomor, Judit Várkonyi, Wolfgang R. Sperr, Martin Werner, Hans Kreipe, Hans-Peter Horny
Publikováno v:
Oncotarget. 1:483-496
The diagnosis, classification, and prognostication of patients with myelodysplastic syndromes (MDS) are usually based on clinical parameters, analysis of peripheral blood and bone marrow smears, and cytogenetic determinants. However, a thorough histo
Autor:
Carlo Aul, Lourdes Florensa, Otto Krieger, Christian Steidl, Guillermo Sanz, Claudia Haferlach, G. Garcia-Manero, Michael Lübbert, Reinhard Stauder, Rosa Collado, Peter Valent, Miguel A. Sanz, José Cervera, Thomas Noesslinger, Maria-Jose Calasanz, Julie Schanz, Kazuma Ohyashiki, Leonor Arenillas, J M Hernández, Barbara Hildebrandt, Carmen Pedro, María-Luisa Martín, Esperanza Such, Teresa Vallespi, Javier Grau, Ana Valencia, E. Luño, A.A.N. Giagounidis, Ulrich Germing, Sabine Blum, Michael Pfeilstöcker, Mar Mallo, D. Haase, Blanca Espinet, C. Fonatsch, Francesc Solé
Publikováno v:
Leukemia, vol. 25, no. 1, pp. 110-120
This cooperative study assessed prognostic factors for overall survival (OS) and risk of transformation to acute myeloid leukemia (AML) in 541 patients with de novo myelodysplastic syndrome (MDS) and deletion 5q. Additional chromosomal abnormalities
Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes
Autor:
Thomas Nösslinger, Reinhard Stauder, Peter Valent, Michael Lübbert, Heinz Tüchler, Otto Krieger, Aristoteles Giagounidis, Detlef Haase, Wolfgang R. Sperr, Ulrich Germing, Michael Pfeilstöcker
Publikováno v:
Annals of Oncology. 21:120-125
Background The International Prognostic Scoring System (IPSS) is the golden standard to assess prognosis in myelodysplastic syndromes (MDS). The aim of this analysis was to study age and gender as interacting variables for individualized prognosticat
Autor:
Reinhard Stauder, Michael Kundi, Otto Krieger, Friedrich Wimazal, Peter Valent, A. Makrai, Christian Baumgartner, Thomas Nösslinger, W. R. Sperr, Michael Pfeilstöcker
Publikováno v:
Annals of Oncology. 21:114-119
Background: The evaluation of comorbidity is of increasing importance in patients with hematologic disorders. Patients and methods: In the present study, the influence of comorbidity on survival and acute myeloid leukemia (AML) evolution was analyzed
Autor:
Michael Girschikofsky, Otto Krieger, Hanns Hauser, Hedwig Kasparu, Otto Zach, Rainer Oberbauer, Dieter Lutz, Josef Koenig
Publikováno v:
Blood. 112:2156-2159
A single nucleotide polymorphism (SNP) responsible for lactase persistence (LCT −13910C>T) changes intestinal microflora. Considering the influence of bacterial microflora on various immune effects, we tested DNA from 111 recipients/donors and anal
Autor:
Thomas Nösslinger, Reinhard Stauder, Otto Krieger, Michael Pfeilstöcker, Heinz Sill, Friedrich Wimazal, Peter Bettelheim, Peter Valent, Wolfgang R. Sperr
Publikováno v:
European Journal of Clinical Investigation
Transfusion-related morbidity is an emerging challenge in chronically transfused patients with low-risk myelodysplastic syndromes (MDS). In these patients, transfusion-induced iron overload may represent a leading medical problem. However, although i